Australia markets closed

Telix Pharmaceuticals Limited (TLX.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
19.05+0.02 (+0.11%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
496,659
496,659
155,984
4,898
4,680
Cost of revenue
188,157
188,157
61,556
2,548
2,024
Gross profit
308,502
308,502
94,428
2,350
2,656
Operating expenses
Research development
128,844
128,844
57,857
34,135
23,085
Selling general and administrative
133,852
133,852
93,504
40,810
19,208
Total operating expenses
269,266
269,266
189,444
101,150
52,442
Operating income or loss
39,236
39,236
-95,016
-98,800
-49,786
Interest expense
13,136
13,136
6,416
5,218
1,175
Total other income/expenses net
-30,139
-30,139
3,086
23,553
2,959
Income before tax
3,087
3,087
-98,622
-80,465
-47,935
Income tax expense
-2,124
-2,124
5,457
45
-3,048
Income from continuing operations
5,211
5,211
-104,079
-80,510
-44,887
Net income
5,211
5,211
-104,079
-80,510
-44,887
Net income available to common shareholders
5,211
5,211
-104,079
-80,510
-44,887
Basic EPS
0.00
0.02
-0.34
-0.28
-0.17
Diluted EPS
0.00
0.02
-0.34
-0.28
-0.17
Basic average shares
90,077
319,181
310,644
282,206
257,271
Diluted average shares
90,077
319,181
310,644
282,206
257,271